antirheumatics/erbrechen

Der Link wird in der Zwischenablage gespeichert

ArtikelKlinische VersuchePatente

Wählen Sie den Sortiertyp

Seite 1 von 31 Ergebnisse

Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND It has been reported that antibodies to oral anaerobic bacteria are elevated in the serum and synovial fluids of patients with rheumatoid arthritis. Macrolide antibiotics are active against oral anaerobic bacteria. OBJECTIVE The aim of this work was to evaluate the clinical efficacy of

Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil).

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE Methotrexate (MTX) is an increasingly popular anti-rheumatic drug with its usefulness limited by toxicity, most commonly gastrointestinal (GI). The aim of the study was to study the effectiveness of the 5-HT3 receptor antagonist granisetron (GR) in the therapy of MTX-induced

Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The objective of the study was to determine the frequency of methotrexate intolerance in rheumatoid arthritis (RA) patients by applying the methotrexate intolerance severity score (MISS) questionnaire and to see the effect of dose and concomitant use of other disease-modifying antirheumatic drugs

Low-dose Methotrexate Toxicity in the Setting of Vancomycin-induced Acute Kidney Injury

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

Methotrexate is a disease-modifying anti rheumatic drug (DMARD) that is often used in low dosages as the first line drug for rheumatoid arthritis patients. The chemotherapeutic agent works by inhibiting dihydrofolate reductase, and the primary route of clearance of the drug is via the kidneys.

[Treatment with low-dose methotrexate in chronic polyarthritis. Review of the literature].

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The therapeutic effect of low-dose MTX-treatment (10-25 mg/week) in active rheumatoid arthritis can be demonstrated by an improvement in clinical and laboratory parameters of disease activity already after 4-6 weeks. The mode of action is not fully understood. Direct anti-inflammatory effects seem

[Methotrexate in the therapy of juvenile idiopathic arthritis].

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

Treatment with low-dose methotrexate (MTX) is an important element in the therapy of juvenile idiopathic arthritis (JIA). It could be demonstrated in placebo-controlled trials that MTX is a safe and effective drug which is generally well tolerated by children and adolescents. MTX is usually used at

Apremilast (Otezla). No progress in plaque psoriasis or psoriatic arthritis.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

When PUVA therapy and immunosuppressants such as methotrexate are ineffective, TNF alpha antagonists are an option for patients with severe plaque psoriasis, in the absence of a better alternative. This is also the case for patients with psoriatic arthritis after failure of a "disease-modifying"

A case of urinary incontinence by hydroxychloroquine in a geriatric patient.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE Rheumatoid arthritis is an autoimmune disorder characterized by persistent synovitis and systemic inflammation. Genetic factors account for approximately 50% of cases of rheumatoid arthritis and environmental factors include smoking. Urinary incontinence may occur as a medication adverse

Methotrexate in rheumatoid arthritis: a 2 year experience at a university hospital in Pakistan.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

In this study we report our two years experience of methotrexate (MTX) in the management of rheumatoid arthritis (RA) at the Aga Khan University Hospital, Karachi. We studied the clinical course of 124 RA patients. The mean age was 44 +/- 11 years (range 19-72) and mean duration of RA was 5 +/- 4

[Gastrointestinal side effects in the therapy of rheumatologic diseases].

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

Antirheumatic drugs may lead to a number of relevant gastrointestinal complications. Symptomatical treatments with glucocorticoids and non steroidal antirheumatic drugs (NSAD) are known to induce gastric or duodenal ulcers, above all under combination therapies. Side effects of DMARD's

Efficacy and safety of DMARDs in psoriatic arthritis: a systematic review.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE Disease-modifying antirheumatic drugs (DMARDs) are frequently prescribed as a first step therapy in active psoriatic arthritis (PsA). However, evidence is sparse and scattered. The objective of this study is to evaluate the efficacy and safety of DMARDs in PsA. METHODS We performed a

Is thiopurine methyltransferase genetic polymorphism a major factor for withdrawal of azathioprine in rheumatoid arthritis patients?

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE To determine whether the presence of thiopurine methyltransferase (TPMT) alleles associated with reduced or absent activity of thiopurine methyltransferase is a major factor for withdrawal of azathioprine (AZA) in rheumatoid arthritis (RA) patients. METHODS The TPMT genotype, including the

Long-term therapy with tolfenamic acid pINN. A clinical and toxicological study with special reference to clinical and chemical laboratory parameters.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

48 patients with rheumatic diseases underwent long-term treatment with a new antirheumatic compound, tolfenamic acid pINN. The dosage was 2 capsules of 100 mg 3 times daily. At the time of summing-up 9 patients had been treated for one year, 41 for 6 months and 7 had been eliminated after 1 month of

Cyclophosphamide for rheumatoid arthritis.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE To estimate the short-term effects of cyclophosphamide for the treatment of rheumatoid arthritis. METHODS We searched the Cochrane Musculoskeletal Group's Register, the Cochrane Controlled Trials Register, Medline and Embase up to and including July 1997. We also carried out a handsearch

Cyclophosphamide for treating rheumatoid arthritis.

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

OBJECTIVE To assess the short-term effects of cyclophosphamide for the treatment of rheumatoid arthritis. METHODS We searched the Cochrane Musculoskeletal Group's Register, the Cochrane Controlled Trials Register (issue 3, 2000), Medline and Embase up to and including August 2000. We also carried

Bisherige
1
2
3
Nächster

Treten Sie unserer
Facebook-Seite bei

Herbal & Natural Medicine

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

Arbeitet in 55 Sprachen
Von der Wissenschaft unterstützte Kräuterkuren
Kräutererkennung durch Bild
Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
Suchen Sie nach Heilkräutern nach ihrer Wirkung
Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen